TPIV 200

DB17318InvestigationalVaccines

TPIV 200 is a vaccine consisting of proteins from the folate receptor alpha mixed with Granulocyte-macrophage colony-stimulating factor (GM-CSF).

Also known as
TPIV200/huFR-1
Code names
TPIV 200

What you can answer from here — as of April 23, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of TPIV 200, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In